A carregar...
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Tumor necrosis factor alpha (TNF-?) is an important pro-inflammatory cytokine associated with a variety of ocular diseases. The currently available TNF-? inhibitors are etanercept, infliximab, adalimumab, golimumab, and certolizumab. Experimental and clinical studies on the intravitreal use of these...
Na minha lista:
| Publicado no: | J Ophthalmic Inflamm Infect |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4372686/ https://ncbi.nlm.nih.gov/pubmed/25825604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12348-014-0026-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|